Rollins Stock: Analyst Estimates & Ratings

Atlanta, Georgia-based Rollins, Inc. (ROL) provides pest and wildlife control services and protection to residential and commercial customers in the United States and internationally. The company has a market cap of $25.4 billion and offers pest control services to residential properties, as well as workplace pest control solutions for customers across various end markets.

ROL shares have lagged behind the broader market over the past year, declined 2.8% compared to the S&P 500 Index ($SPX) 27.3% surge. Moreover, in 2026, the stock has fallen nearly 11%, underperforming the SPX’s 9.6% rise as well.

More News from Barchart

Buying CBRS Stock After the Cerebras IPO Is a Bet on Engineering Magic. That Same Magic Could Be the Kiss of Death. Meta Stock vs. Google Stock: One Is Clearly the Better Buy for the Next 10 Years Elon Musk’s Terafab Could Make Intel Stock More Exciting for Long-Term Investors Than Wall Street Ever Thought Was Possible Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else.

Focusing on its industry benchmark, the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) has risen 9.8% over the past year, outperforming the stock. In 2026, XLY has declined marginally and has also rallied the stock.www.barchart.com

On Apr. 22, ROL stock rose 1.1% following the release of its better-than-expected Q1 2026 earnings. The company’s revenue for the quarter amounted ot $906.4 million and surpassed the Street’s estimates. Moreover, its adjusted EPS came in at $0.24, also coming in on top of Wall Street’s forecasts.

For the current year, which ends in December, analysts expect ROL’s EPS to rise 10.7% to $1.24 on a diluted basis. The company met and surpassed the consensus estimate in three of the last four quarters, while missing on one occasion.

Among the 17 analysts covering ROL stock, the consensus is a “Moderate Buy.” That’s based on 10 “Strong Buy” ratings, two “Moderate Buys,” and five “Holds.”www.barchart.com

The configuration has turned more bullish over the past month.

On Apr. 24, UBS analyst Joshua Chan maintained a “Neutral” rating on Rollins stock and raised its price target from $58 to $61.

UBS’s mean price target of $65.40 indicates a premium of 22.4% from the current market prices. Its Street-high target of $72 suggests a robust 34.8% upside potential from current price levels.

On the date of publication, Aritra Gangopadhyay did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

View Comments